Amblitel News & Events


Archive for October, 2012

FDA Warns Against Infection Risk From Ophthalmic Drugs Following Meningitis Outbreak

Added 10.22.12

As the investigation into the meningitis outbreak continues, the FDA is recommending that any patients who received injectable drugs purchased from or compounded at the New England Compounding Center after May 21, 2012, be notified of the potential risk of infection, according to an ASCA report. Here's the link to the entire article from Becker's ASC Review and a link to the ASCA report: more...

Ambulatory Surgery Centers and Physician Offices Less Costly Than Hospitals

Added 10.22.12

More and more outpatient surgical procedures are being done at nonhospital-based facilities such as freestanding ambulatory surgical centers and physician offices, instead of at hospital-based outpatient departments. A new study comparing the cost to Medicare of 22 urological surgical procedures performed in each setting has found that ambulatory surgery centers and physician offices are less costly than hospitals. The results are published in the December issue of The Journal of Urology. Read the rest of this article from at: more...

FDA Statement on Fungal Meningitis Outbreak: Additional Patient Notification Advised

Added 10.19.12

The CDC and FDA have confirmed the presence of a fungus known as Exserohilum rostratum in unopened medication vials of preservative-free methylprednisolone acetate (80mg/ml) from one of the three implicated lots from NECC (Lot #08102012@51, BUD 2/6/2013).  The laboratory confirmation further links steroid injections from these lots from NECC to the multistate outbreak of fungal meningitis and joint infections.  Testing on the other two implicated lots of methylprednisolone acetate and other NECC injectables continues. CDC and state health departments estimate that approximately 14,000 patients may have received injections with medication from three implicated lots of methylprednisolone and nearly 97% of these patients have been contacted for further follow-up. There is now available a Patient Notification Letter on the FDA "Update on Fungal... more...

Paul Davis Named As One Of The 430 People To Know In The ASC Industry

Added 10.19.12

Amblitel's CEO and President, Paul Davis, was named in the recent Becker's Spine Review as one of the 430 people to know in the ambulatory surgery center industry. Congratulations! more...

National Ambulatory Surgery Center Day is Today!

Added 10.11.12

Is your center hosting an event? This is an excellent opportunity to let government officials, policy makers, the residents of your community and local media know about all the advantages and benefits ASCs provide the healthcare community. William Prentice, ASCA Chief Executive Officer, stated earlier this year that “National ASC Day 2012 provides the ideal opportunity for ASCs to demonstrate their value to policy makers and the public. ASCs are often the first choice of doctors and patients because they offer outstanding surgical care while also providing convenience, cost savings and a comforting environment where highly skilled staff and physicians put patients first.” Let us know what you did (health fair, open house, etc.) and the success you saw from... more...